Results 291 to 300 of about 8,790,513 (336)
Some of the next articles are maybe not open access.
UNCERTAINTY OF INCREMENTAL COST-EFFECTIVENESS RATIOS
International Journal of Technology Assessment in Health Care, 1999Objective: To compare different methods to estimate the confidence interval of the incremental cost-effectiveness ratio (ICER).Methods: The adequacy of Fieller intervals and three methods for calculating bootstrap intervals are compared based on a simulation of 10,000 trials, using data from one trial.Results: Both Fieller and bootstrap methods lead
J. L. Severens +2 more
semanticscholar +4 more sources
On Estimating Medical Cost and Incremental Cost‐Effectiveness Ratios with Censored Data
Biometrics, 2001Medical cost estimation is very important to health care organizations and health policy makers. We consider cost-effectiveness analysis for competing treatments in a staggered-entry, survival-analysis-based clinical trial. We propose a method for estimating mean medical cost over patients in such settings.
Hong-Wei Zhao, Lili Tian
semanticscholar +3 more sources
Cost-effectiveness, QALYs, and incremental cost-effectiveness ratios
Seminars in Spine Surgery, 2014The cost of healthcare in the United States has continued to grow at an unsustainable rate. Spine care has not been immune to these elevating costs. Given the current economic environment, policy makers and payers have started to consider a move towards a system of value-based healthcare.
Ravi R. Patel +2 more
openaire +1 more source
Acceptable Incremental Cost Effectiveness Ratio for Use of New Drugs, Cases in Statin Therapies
Yakugaku Zasshi, 2010 As it is an urgent issue to contain increasing healthcare expenditures, unlimited reimbursement of pharmaceuticals continues to be controversial. The objective of this study is to identify acceptable incremental cost effectiveness ratios between new and conventional therapies.
Makoto Shiragami
exaly +4 more sources
Biometrics, 2006
SummaryWith medical costs escalating over recent years, cost analysis is being conducted more and more to assess economic impact of new treatment options. An incremental cost‐effectiveness ratio (ICER) is a measure that assesses the additional cost for a new treatment for each additional unit of effectiveness, such as saving 1 year of life.
Wang, Hongkun, Zhao, Hongwei
openaire +3 more sources
SummaryWith medical costs escalating over recent years, cost analysis is being conducted more and more to assess economic impact of new treatment options. An incremental cost‐effectiveness ratio (ICER) is a measure that assesses the additional cost for a new treatment for each additional unit of effectiveness, such as saving 1 year of life.
Wang, Hongkun, Zhao, Hongwei
openaire +3 more sources
Future Oncology, 2020
Background: To investigate the cost-effectiveness of nivolumab versus chemotherapy in the second-line treatment for advanced esophageal squamous cell carcinoma.
Pengfei Zhang, D. Xie, Qiu Li
semanticscholar +1 more source
Background: To investigate the cost-effectiveness of nivolumab versus chemotherapy in the second-line treatment for advanced esophageal squamous cell carcinoma.
Pengfei Zhang, D. Xie, Qiu Li
semanticscholar +1 more source
The precision of regression-type estimator for incremental cost–effectiveness ratio
Journal of Statistical Computation and Simulation, 2012The estimation of incremental cost–effectiveness ratio (ICER) has received increasing attention recently. It is expressed in terms of the ratio of the change in costs of a therapeutic intervention to the change in the effects of the intervention. Despite the intuitive interpretation of ICER as an additional cost per additional benefit unit, it is a ...
Chien-Hua Wu, Shu-Mei Wan
openaire +1 more source
Circulation. Cardiovascular Quality and Outcomes
BACKGROUND: Although clinical benefits of intravascular imaging-guided percutaneous coronary intervention (PCI) in patients with complex coronary artery lesions have been observed in previous trials, the cost-effectiveness of this strategy is uncertain ...
D. Hong +27 more
semanticscholar +1 more source
BACKGROUND: Although clinical benefits of intravascular imaging-guided percutaneous coronary intervention (PCI) in patients with complex coronary artery lesions have been observed in previous trials, the cost-effectiveness of this strategy is uncertain ...
D. Hong +27 more
semanticscholar +1 more source
International Journal of Technology Assessment in Health Care, 2018
Introduction:Current practice in cost-effectiveness analysis (CEA) involves the estimation of the incremental cost-effectiveness ratio (ICER) between a new intervention and one alternative comparator reflecting the standard of care. As this focuses on pairwise comparisons, rather than considering the whole range of available alternatives at any given ...
Stefano Lucherini +2 more
openaire +1 more source
Introduction:Current practice in cost-effectiveness analysis (CEA) involves the estimation of the incremental cost-effectiveness ratio (ICER) between a new intervention and one alternative comparator reflecting the standard of care. As this focuses on pairwise comparisons, rather than considering the whole range of available alternatives at any given ...
Stefano Lucherini +2 more
openaire +1 more source
Incremental cost-effectiveness ratio (ICER)
Abstract The incremental cost-effectiveness ratio (ICER) is an analysis used to summarize the cost-effectiveness of a healthcare intervention. An overview of the ICER principles is followed by a description of ICER thresholds and the approach to calculating ICERs.Phil Ambery +2 more
openaire +1 more source